planningFind a Tender · planning Update

National Generic Pharmaceuticals – Project Revive

BuyerNHS England

Statusplanning

DeadlineNot published

Value£1

Published20 Aug 2026

What is being bought

National Generic Pharmaceuticals – Project Revive DCE/DSW regions – 01/04/27 to 31/01/29 (22 months) DLS/DNE regions – 01/04/27 to 31/01/29 (22 months) DLN/DNW regions – 01/04/27 to 31/01/29 (22 months)

Lot details

Lot 1

No lot description published.

Statusplanning

Contract periodFrom 1 Apr 2027 to 31 Jan 2029

SME suitabilitySuitable for SMEs

What is included

Item	Category	Quantity
1	Pharmaceutical products	Not published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 33. The category anchor is Pharmaceutical products (33600000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison set	Procedures	Reported bids per procedure	Named award suppliers	Price evidence
Market: CPV division 33	3,354	2 median · 115.5 average (1,458 of 3,354 with a bid count)	5.9 average (1,735 of 3,354 with named award suppliers)	Not published
Same buyer	54	Not published	Not published	Not published
Similar published value (0.5×–2×)	53	Not published	Not published	Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementYes

Dynamic purchasing systemNot published

Competitive procurementNot published

Recurring requirementNot published

Procurement method rationaleNot published

Rationale classificationsNot published

Special regimeNot published

Covered byNot published

Submission policyNot published

Selection criteriaNot published

Risk detailsNot published

Planning & early market engagement

BudgetValue not published

No-engagement rationaleNot published

Planning documents1

Planning milestones1

Milestone	Type	Due	Status
NHS England is advising suppliers of an upcoming tender for the NHS National Generic Framework – Project Revive to commence on 1st April 2027 for 22 months with the option to extend to a maximum total contract length of 48 months. Project Revive was announced as an action to be delivered in the Government’s Supply Resilience Strategy, published August 2025. Project Revive is a collaboration between NHS England, MHRA and Medicines UK. This is a project aimed at reactivating dormant licences and seeking new supply routes in strategically important areas to support supply from late this year / early 2027. Project Revive will focus on secondary care supply chain resilience only. The programme aims to strengthen supply chain resilience and patient access by reactivating dormant/not marketed MHRA approved Marketing Authorisations for critical products. The purpose of this notice is to inform existing and potential new suppliers of this procurement. Useful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ . Specific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly.	engagement	25 Sept 2026	scheduled

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

Preliminary market engagement notice on Find a Tender planning · marketEngagementNotice

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCID	ocds-h6vhtk-06e1ed
Latest release ID	079388-2026
Latest release timestamp	Thu Aug 20 2026 10:54:57 GMT+0000 (Coordinated Universal Time)
Source	find-a-tender
Official notice URL	Not published
Tender status	planning
Procurement method	Not published
Procurement method details	Not published
Main procurement category	goods
Above threshold	Yes
Legal basis	2023/54
Tender period: start	Not published
Tender period: end	Not published
Expression of interest deadline	Not published
Enquiry deadline	Not published
Award period: start	Not published
Award period: end	Not published
Submission method details	Not published
Submission languages	Not published
Electronic catalogue policy	Not published
Total tender value	£1
Tender lots in source	1
Tender items in source	1
Tender documents in source	0
Awards in latest release	0
Contracts in latest release	0
Parties in latest release	1

Notice history

Date	Event	Reference
20 Aug 2026	planningUpdate	079388-2026
12 Aug 2026	planning	076471-2026

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON

{
  "id": "079388-2026",
  "tag": [
    "planningUpdate"
  ],
  "date": "2026-08-20T11:54:57+01:00",
  "ocid": "ocds-h6vhtk-06e1ed",
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "tender": {
    "id": "CM/PHG/26/5767",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2029-01-31T23:59:59Z",
          "startDate": "2027-04-01T00:00:00+01:00",
          "maxExtentDate": "2031-03-31T23:59:59+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "National Generic Pharmaceuticals – Project Revive",
    "value": {
      "amount": 1,
      "currency": "GBP",
      "amountGross": 1.2
    },
    "status": "planning",
    "amendments": [
      {
        "id": "079388-2026",
        "description": "Date for tender issue has been moved to 01/10/26 with engagement process up to 25/9/26"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "National Generic Pharmaceuticals – Project Revive\nDCE/DSW regions – 01/04/27 to 31/01/29 (22 months)\nDLS/DNE regions – 01/04/27 to 31/01/29 (22 months)\nDLN/DNW regions – 01/04/27 to 31/01/29 (22 months)",
    "communication": {
      "futureNoticeDate": "2026-10-01T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PDPT-3135-BWWY",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI45",
        "country": "GB",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "england.generics@nhs.net"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "079388-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/079388-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-08-20T11:54:57+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-09-25T23:59:59+01:00",
        "description": "NHS England is advising suppliers of an upcoming tender for the NHS National Generic Framework – Project Revive to commence on 1st April 2027 for 22 months with the option to extend to a maximum total contract length of 48 months.\nProject Revive was announced as an action to be delivered in the Government’s Supply Resilience Strategy, published August 2025.\nProject Revive is a collaboration between NHS England, MHRA and Medicines UK. This is a project aimed at reactivating dormant licences and seeking new supply routes in strategically important areas to support supply from late this year / early 2027. Project Revive will focus on secondary care supply chain resilience only.\nThe programme aims to strengthen supply chain resilience and patient access by reactivating dormant/not marketed MHRA approved Marketing Authorisations for critical products.\nThe purpose of this notice is to inform existing and potential new suppliers of this procurement.\nUseful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ .\nSpecific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly."
      }
    ]
  },
  "initiationType": "tender"
}

Complete JSON history (2 releases)

20 Aug 2026 · 079388-2026 · planningUpdate

{
  "id": "079388-2026",
  "tag": [
    "planningUpdate"
  ],
  "date": "2026-08-20T11:54:57+01:00",
  "ocid": "ocds-h6vhtk-06e1ed",
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "tender": {
    "id": "CM/PHG/26/5767",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2029-01-31T23:59:59Z",
          "startDate": "2027-04-01T00:00:00+01:00",
          "maxExtentDate": "2031-03-31T23:59:59+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "National Generic Pharmaceuticals – Project Revive",
    "value": {
      "amount": 1,
      "currency": "GBP",
      "amountGross": 1.2
    },
    "status": "planning",
    "amendments": [
      {
        "id": "079388-2026",
        "description": "Date for tender issue has been moved to 01/10/26 with engagement process up to 25/9/26"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "National Generic Pharmaceuticals – Project Revive\nDCE/DSW regions – 01/04/27 to 31/01/29 (22 months)\nDLS/DNE regions – 01/04/27 to 31/01/29 (22 months)\nDLN/DNW regions – 01/04/27 to 31/01/29 (22 months)",
    "communication": {
      "futureNoticeDate": "2026-10-01T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PDPT-3135-BWWY",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI45",
        "country": "GB",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "england.generics@nhs.net"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "079388-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/079388-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-08-20T11:54:57+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-09-25T23:59:59+01:00",
        "description": "NHS England is advising suppliers of an upcoming tender for the NHS National Generic Framework – Project Revive to commence on 1st April 2027 for 22 months with the option to extend to a maximum total contract length of 48 months.\nProject Revive was announced as an action to be delivered in the Government’s Supply Resilience Strategy, published August 2025.\nProject Revive is a collaboration between NHS England, MHRA and Medicines UK. This is a project aimed at reactivating dormant licences and seeking new supply routes in strategically important areas to support supply from late this year / early 2027. Project Revive will focus on secondary care supply chain resilience only.\nThe programme aims to strengthen supply chain resilience and patient access by reactivating dormant/not marketed MHRA approved Marketing Authorisations for critical products.\nThe purpose of this notice is to inform existing and potential new suppliers of this procurement.\nUseful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ .\nSpecific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly."
      }
    ]
  },
  "initiationType": "tender"
}

12 Aug 2026 · 076471-2026 · planning

{
  "id": "076471-2026",
  "tag": [
    "planning"
  ],
  "date": "2026-08-12T08:24:49+01:00",
  "ocid": "ocds-h6vhtk-06e1ed",
  "buyer": {
    "id": "GB-PPON-PDPT-3135-BWWY",
    "name": "NHS England"
  },
  "tender": {
    "id": "CM/PHG/26/5767",
    "lots": [
      {
        "id": "1",
        "status": "planning",
        "hasRenewal": true,
        "suitability": {
          "sme": true
        },
        "contractPeriod": {
          "endDate": "2029-01-31T23:59:59Z",
          "startDate": "2027-04-01T00:00:00+01:00",
          "maxExtentDate": "2031-03-31T23:59:59+01:00"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "additionalClassifications": [
          {
            "id": "33600000",
            "scheme": "CPV",
            "description": "Pharmaceutical products"
          }
        ]
      }
    ],
    "title": "National Generic Pharmaceuticals – Project Revive",
    "value": {
      "amount": 1,
      "currency": "GBP",
      "amountGross": 1.2
    },
    "status": "planning",
    "legalBasis": {
      "id": "2023/54",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents",
      "scheme": "UKPGA"
    },
    "techniques": {
      "hasFrameworkAgreement": true
    },
    "description": "National Generic Pharmaceuticals – Project Revive\nDCE/DSW regions – 01/04/27 to 31/01/29 (22 months)\nDLS/DNE regions – 01/04/27 to 31/01/29 (22 months)\nDLN/DNW regions – 01/04/27 to 31/01/29 (22 months)",
    "communication": {
      "futureNoticeDate": "2026-08-26T23:59:59+01:00"
    },
    "aboveThreshold": true,
    "mainProcurementCategory": "goods"
  },
  "parties": [
    {
      "id": "GB-PPON-PDPT-3135-BWWY",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI45",
        "country": "GB",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "publicAuthorityCentralGovernment",
            "scheme": "UK_CA_TYPE",
            "description": "Public authority - central government"
          }
        ]
      },
      "identifier": {
        "id": "PDPT-3135-BWWY",
        "scheme": "GB-PPON"
      },
      "contactPoint": {
        "email": "england.generics@nhs.net"
      }
    }
  ],
  "language": "en",
  "planning": {
    "documents": [
      {
        "id": "076471-2026",
        "url": "https://www.find-tender.service.gov.uk/Notice/076471-2026",
        "format": "text/html",
        "noticeType": "UK2",
        "description": "Preliminary market engagement notice on Find a Tender",
        "documentType": "marketEngagementNotice",
        "datePublished": "2026-08-12T08:24:49+01:00"
      }
    ],
    "milestones": [
      {
        "id": "engagement",
        "type": "engagement",
        "status": "scheduled",
        "dueDate": "2026-08-25T23:59:59+01:00",
        "description": "NHS England is advising suppliers of an upcoming tender for the NHS National Generic Framework – Project Revive to commence on 1st April 2027 for 22 months with the option to extend to a maximum total contract length of 48 months.\nProject Revive was announced as an action to be delivered in the Government’s Supply Resilience Strategy, published August 2025.\nProject Revive is a collaboration between NHS England, MHRA and Medicines UK. This is a project aimed at reactivating dormant licences and seeking new supply routes in strategically important areas to support supply from late this year / early 2027. Project Revive will focus on secondary care supply chain resilience only.\nThe programme aims to strengthen supply chain resilience and patient access by reactivating dormant/not marketed MHRA approved Marketing Authorisations for critical products.\nThe purpose of this notice is to inform existing and potential new suppliers of this procurement.\nUseful information for suppliers can be found here: https://www.england.nhs.uk/medicines-2/medicines-value-and-access/medicines-procurement-and-supply-chain/ and the current generics workplan here: https://www.england.nhs.uk/publication/generics-framework-workplan-by-product-report/ .\nSpecific information regarding the products included in this procurement will be provided in the ITO, which will be issued shortly."
      }
    ]
  },
  "initiationType": "tender"
}